黑貓股份(002068.SZ):2020年限制性股票激勵計劃獲景德鎮市國資委批覆
格隆匯8月6日丨黑貓股份(002068.SZ)公佈,近日,公司收到景德鎮市國有資產監督管理委員會下發的《關於江西黑貓炭黑股份有限公司實施2020年限制性股票激勵計劃的批覆》(景國資發[2020]47號),主要內容如下:
1、原則同意黑貓股份實施限制性股票激勵計劃及其限制性股票激勵計劃的業績考核目標。
2、黑貓股份此次限制性股票激勵計劃等相關事項尚需提交股東大會審議通過後方可實施。
3、公司要按照中國證監會、國務院國資委相關文件要求,規範做好限制性股票激勵計劃工作,做到依法合規操作,規範信息披露。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.